4
Changes in Ownership
Vanda Pharmaceuticals Inc. Filed Acc 0001209191-16-090125
SVP, CFO, Sec & Treasurer sold 9,564 shares at $8.96 ($85,693)
- SVP, CFO, Sec & Treasurer acquired 17,032 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Kelly James Patrick · SVP, CFO, Sec & Treasurer
Table I: Non-derivative
5 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2016-01-04 | Exercise or conversion : show line 1 in the form | +4,688 | 57,992 | D | ||
| 2016-01-04 | Exercise or conversion : show line 2 in the form | +2,344 | 60,336 | D | ||
| 2016-01-04 | Exercise or conversion : show line 3 in the form | +5,000 | 65,336 | D | ||
| 2016-01-04 | Exercise or conversion : show line 4 in the form | +5,000 | 70,336 | D | ||
| 2016-01-04 | Sale : show line 5 in the form | −9,564 | $8.96 | $85,693 | 60,772 | D |
| Open-market sales · 9,564 sh · avg $8.96 · $85,693 | ||||||
Table II: Derivative
4 lines| Date | Transaction | Shares | Underlying | Owned after | D/I |
|---|---|---|---|---|---|
| 2016-01-04 | Exercise or conversion : show line 6 in the form Restricted Stock Unit | −4,688 | 4,688 | 0 | D |
| 2016-01-04 | Exercise or conversion : show line 7 in the form Restricted Stock Unit | −2,344 | 2,344 | 2,344 | D |
| 2016-01-04 | Exercise or conversion : show line 8 in the form Restricted Stock Unit | −5,000 | 5,000 | 10,000 | D |
| 2016-01-04 | Exercise or conversion : show line 9 in the form Restricted Stock Unit | −5,000 | 5,000 | 15,000 | D |
Loading xslF345X03/doc4.xml…